Feature | Cases | PRO2000/ANCCA | P-value | ||
---|---|---|---|---|---|
- | + | ++ | |||
Gender | Â | Â | Â | Â | 0.697 |
Male | 96 | 38 | 46 | 12 | Â |
Female | 11 | 3 | 6 | 2 | Â |
Age (years) | Â | Â | Â | Â | 0.524 |
≤51 | 53 | 23 | 23 | 7 |  |
>51 | 54 | 18 | 29 | 7 | Â |
Serum HBsAg | Â | Â | Â | Â | 0.737 |
Negative | 44 | 17 | 20 | 7 | Â |
Positive | 63 | 24 | 32 | 7 | Â |
Serum AFP (ng/ml) | Â | Â | Â | Â | 0.703 |
≤20 | 48 | 18 | 25 | 5 |  |
>20 | 59 | 23 | 27 | 9 | Â |
Tumor size (cm) | Â | Â | Â | Â | 0.107 |
≤5 | 55 | 25 | 26 | 4 |  |
>5 | 52 | 16 | 26 | 10 | Â |
Tumor number | Â | Â | Â | Â | 0.003 |
Single | 80 | 38 | 32 | 10 | Â |
Multiple | 27 | 3 | 20 | 4 | Â |
Tumor differentiation | Â | Â | Â | Â | <0.001 |
I-II | 76 | 40 | 34 | 2 | Â |
III-IV | 31 | 1 | 18 | 12 | Â |
Cirrhosis | Â | Â | Â | Â | 0.519 |
Negative | 51 | 21 | 22 | 8 | Â |
Positive | 56 | 20 | 30 | 6 | Â |
TNM stage | Â | Â | Â | Â | <0.001 |
I-II | 81 | 41 | 38 | 2 | Â |
III-IV | 26 | 0 | 14 | 12 | Â |
Tumor microsatellite | Â | Â | Â | Â | 0.011 |
Absent | 77 | 36 | 31 | 10 | Â |
Present | 30 | 5 | 21 | 4 | Â |
Portal vein tumor thrombus | Â | Â | Â | Â | <0.001 |
Absent | 96 | 41 | 47 | 8 | Â |
Present | 11 | 0 | 5 | 6 | Â |
Recurrence | Â | Â | Â | Â | <0.001 |
Absent | 89 | 39 | 43 | 7 | Â |
Present | 18 | 2 | 9 | 7 | Â |